Download Now

Your Token Count

0

Sign in to Purchase/Download Documents

Sign in / Register

User login

Social Networking

Support Free Media

Policosanol

Policosanol

User Options

A Membership is required. Please Login or Create an account to get started

Request us to build a Downloadable Document Product on this Topic

Make a Request for GMI to add more Articles on this Topic Immediately (Purchase Required)

View a Printer Friendly version of this page

E-mail this page to a friend

Perform a Search with this Topic

Hover over an icon for more information

Additional Topics Details for this Page

Article Count - 22
Cumulative Knowledge - 162

Advanced Database Options

Limit Articles Displayed by the Following Study Types

Available Sorting Options

Limited to Members Only

By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by clicking here. If you do not currently have a user account, and would like to create one/become a member, click here to begin the singup process.

Currently Available Sorting Options

Article Published Date - Sort all displayed articles by their published date
Quick Summary Fieldsets - Sort alphabetically, rather than by Cumulative Knowledge
Cumulative Knowledge - Default sorting method. Allows you to sort descendingly

What is Cumulative Knowledge?

Cumulative Knowledge is determined by ascribing a numerical value to the various study types weighted in descending order as follows: (1) Meta-Analysis; (2) Human Study; (3) Human: Case Study; (4) Animal: Transgenic; (5) Animal; (6) In Vitro; (7) Review; and (8) Commentary.

Click here for a more thorough explanation.

Quick Summary: Current access displays 2 out of 26 associated Diseases

Name	Cumulative Knowledge	Article Count	Focus Articles
Hypercholesterolemia	60	6	Log in \| Sign up
Intermittent Claudication	40	4	Log in \| Sign up

Quick Summary: Current access displays 2 out of 4 associated Pharmacological Actions

Name	Cumulative Knowledge	Article Count	Focus Articles
Anticholesteremic Agents	22	3	Log in \| Sign up
Anti-Platelet	10	1	Log in \| Sign up

Currently Viewing Free Sample of Member Only Features

Although all 19,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 2 rows, of the membership feature called "Cumulative Knowledge" (learn more).

The Focus Article Feature is not enabled.

Upgrading to the Member role gives you access to unlimited rows of Cumulative Knowledge data.

To Participate

Click here to login
Click here to create an account

View the Evidence: Substances

A combination of berberine, red yeast rice and policosanol lowers lipid levels and improves endothelial function and insulin sensitivity in hypercholesterolemic patients.

Click here to read the entire abstract

Pubmed Data : Nutr Metab Cardiovasc Dis. 2009 Aug 19. Epub 2009 Aug 19. PMID: 19699071

Article Published Date : Aug 19, 2009

Study Type : Human Study

Additional Links

Substances : Berberine : CK(156) : AC(75), Policosanol : CK(184) : AC(22), Red Yeast Rice : CK(164) : AC(25)

Diseases : Endothelial Dysfunction : CK(897) : AC(173), Hypercholesterolemia : CK(1517) : AC(165), Insulin Resistance : CK(1034) : AC(221)

Echinacea significantly reduced plasma concentrations of S-warfarin. However, neither echinacea nor policosanol significantly affected warfarin pharmacodynamics, platelet aggregation or baseline clotting status in healthy subjects.

Click here to read the entire abstract

Pubmed Data : J Ethnopharmacol. 2006 Jul 19;106(3):321-6. Epub 2006 Mar 6. PMID: 20573086

Article Published Date : Jul 19, 2006

Study Type : Human Study

Additional Links

Substances : Echinacea : CK(469) : AC(88), Policosanol : CK(184) : AC(22)

Diseases : Clotting : CK(177) : AC(36)

Additional Keywords : Drug Interaction : CK(64) : AC(8)

Policosanol (20 mg day) is as effective as aspirin (100 mg day) as a platelet aggregation inhibitor.

Click here to read the entire abstract

Pubmed Data : Pharmacol Res. 1997 Oct;36(4):293-7. PMID: 9425618

Article Published Date : Oct 01, 1997

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Blood Coagulation Disorders : CK(42) : AC(8), Clotting : CK(177) : AC(36)

Pharmacological Actions : Platelet Aggregation Inhibitors : CK(173) : AC(37)

Additional Keywords : Aspirin Alternatives : CK(24) : AC(4), Natural Substances Versus Drugs : CK(988) : AC(165)

Policosanol administered to patients suffering ischemic stroke treated with aspirin and vitamins showed good results on neurological outcomes and recurrent events.

Click here to read the entire abstract

Pubmed Data : Indian Pediatr. 2005 Sep;42(9):877-84. PMID: 17004902

Article Published Date : Sep 01, 2005

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Brain Ischemia : CK(94) : AC(38), Cerebral Ischemia : CK(263) : AC(50), Cerebral Stroke : CK(46) : AC(7), Stroke: Attenuation/Recovery : CK(105) : AC(21)

Pharmacological Actions : Neurorestorative : CK(50) : AC(14)

Additional Keywords : Stroke: Recovery : CK(12) : AC(2)

Policosanol demonstrates long-term usefulness in the treatment of patients with intermittent claudication.

Click here to read the entire abstract

Pubmed Data : J Nutr. 2009 Nov;139(11):2061-6. Epub 2009 Sep 23. PMID: 11228084

Article Published Date : Nov 01, 2009

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Intermittent Claudication : CK(422) : AC(19)

Policosanol is effective in the treatment of High Cholesterol (Hypercholestemia).

Click here to read the entire abstract

Pubmed Data : Pharmacotherapy. 2005 Feb;25(2):171-83. PMID: 15767233

Article Published Date : Feb 01, 2005

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Hypercholesterolemia : CK(1517) : AC(165)

Policosanol is more effective than pravastatin on improving blood lipid profiles, platelet aggregation and endothelemia in older patients with type II hypercholesterolemia and high coronary risk.

Click here to read the entire abstract

Pubmed Data : Zhong Yao Cai. 2003 Jan;26(1):31-2. PMID: 10939028

Article Published Date : Jan 01, 2003

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : High Cholesterol : CK(1718) : AC(198), Hypercholesterolemia : CK(1517) : AC(165)

Additional Keywords : Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Policosanol is superior to Lipitor (atorvastatin) in improving blood lipid profiles and inhibiting platelet aggregation.

Click here to read the entire abstract

Pubmed Data : Clin Drug Investig. 2003;23(10):639-50. PMID: 17535079

Article Published Date : Jan 01, 2003

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Clotting : CK(177) : AC(36), Dyslipidemias : CK(176) : AC(33), Thrombosis : CK(657) : AC(74)

Pharmacological Actions : Anti-Platelet : CK(117) : AC(31)

Additional Keywords : Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Policosanol is superior to lovastatin and simvastatin in positively modulating blood lipid profiles.

Click here to read the entire abstract

Pubmed Data : Rev Med Chil. 1999 Mar;127(3):286-94. PMID: 10436712

Article Published Date : Mar 01, 1999

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Cholesterol: LDL/HDL ratio : CK(432) : AC(58), Hypercholesterolemia : CK(1517) : AC(165)

Pharmacological Actions : Anticholesteremic Agents : CK(669) : AC(142)

Additional Keywords : Drug: Lovastatin : CK(10) : AC(1), Drug: Simvastatin : CK(22) : AC(3), Statin Alternatives : CK(34) : AC(4), Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Policosanol is superior to lovastatin in patients with intermittent claudication.

Click here to read the entire abstract

Pubmed Data : Angiology. 2003 Jan;54(1):25-38. PMID: 12593493

Article Published Date : Jan 01, 2003

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Intermittent Claudication : CK(422) : AC(19)

Additional Keywords : Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Policosanol is superior to the drug besfibrate in lowering blood lipids.

Click here to read the entire abstract

Pubmed Data : Ter Arkh. 2000;72(12):7-10. PMID: 11201841

Article Published Date : Jan 01, 2000

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Hyperlipidemia : CK(1211) : AC(109)

Additional Keywords : Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Policosanol is superior to ticlopidine in patients with intermittent claudication.

Click here to read the entire abstract

Pubmed Data : Angiology. 2004 Jul-Aug;55(4):361-71. PMID: 15258682

Article Published Date : Jul 01, 2004

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Intermittent Claudication : CK(422) : AC(19)

Additional Keywords : Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Policosanol seems to be a very promising phytochemical alternative to classic lipid-lowering agents such as the statins.

Click here to read the entire abstract

Pubmed Data : Am Heart J. 2002 Feb;143(2):356-65. PMID: 11835043

Article Published Date : Feb 01, 2002

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Cholesterol: High : CK(922) : AC(156)

Red yeast rice and policosanol is effective in treating children with high cholesterol.

Click here to read the entire abstract

Pubmed Data : Nutr Metab Cardiovasc Dis. 2010 Feb 10. Epub 2010 Feb 10. PMID: 20153154

Article Published Date : Feb 10, 2010

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22), Red Yeast Rice : CK(164) : AC(25)

Diseases : High Cholesterol: In Children : CK(10) : AC(1), Hypercholesterolemia : CK(1517) : AC(165)

Treatments of policosanol, not aspirin, significantly increased walking distances in patients with intermittent claudication.

Click here to read the entire abstract

Pubmed Data : Angiology. 2008 Jun-Jul;59(3):269-77. Epub 2008 Apr 2. PMID: 18388038

Article Published Date : Jun 01, 2008

Study Type : Human Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Intermittent Claudication : CK(422) : AC(19)

Additional Keywords : Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Policosanol against neointima formation in this experimental model was slightly better than that of lovastatin.

Click here to read the entire abstract

Pubmed Data : Science. 2009 Jul 10;325(5937):201-4. PMID: 11207063

Article Published Date : Jul 10, 2009

Study Type : Animal Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Arteriosclerosis : CK(2154) : AC(123), Intima Media Thickening : CK(1878) : AC(41)

Additional Keywords : Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Policosanol has a endothelium protecting effect in the animal model.

Click here to read the entire abstract

Pubmed Data : J Pharm Pharmacol. 1997 Oct;49(10):999-1002. PMID: 9364410

Article Published Date : Oct 01, 1997

Study Type : Animal Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Endothelial Damage : CK(31) : AC(10), Endothelial Dysfunction : CK(897) : AC(173)

Pharmacological Actions : Anticholesteremic Agents : CK(669) : AC(142)

Policosanol may benefit plaque composition and stability and could explain the protective effects of policosanol on atherosclerosis development

Click here to read the entire abstract

Pubmed Data : Arch Med Res. 2005 Sep-Oct;36(5):441-7. PMID: 16099319

Article Published Date : Sep 01, 2005

Study Type : Animal Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Arterial Plaque : CK(439) : AC(20), Arteriosclerosis : CK(2154) : AC(123)

Additional Keywords : Plaque Stability : CK(2) : AC(1)

Policosanol prevents endothelium injury and reduces significantly intimal thickness of rabbit arteries damaged with forceps

Click here to read the entire abstract

Pubmed Data : J Lipid Res. 2010 Jun;51(6):1416-23. Epub 2010 Jan 13. PMID: 17887938

Article Published Date : Jun 01, 2010

Study Type : Animal Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Endothelial Dysfunction : CK(897) : AC(173), Intima Media Thickening : CK(1878) : AC(41)

Policosanol prevents the development of foam cells in carrageenan-induced granulomas in rats

Click here to read the entire abstract

Pubmed Data : J Pharm Pharmacol. 1996 Mar;48(3):306-9. PMID: 8737059

Article Published Date : Mar 01, 1996

Study Type : Animal Study

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Arteriosclerosis : CK(2154) : AC(123), Granuloma : CK(2) : AC(1)

A variety of nutraceutical strategies hold promise in the prevention of Alzheimer disease.

Click here to read the entire abstract

Pubmed Data : Med Hypotheses. 2006;67(4):682-97. Epub 2006 Jul 7. PMID: 16828233

Article Published Date : Jan 01, 2006

Study Type : Commentary

Additional Links

Substances : Chromium : CK(46) : AC(11), Cinnamon : CK(135) : AC(61), Cocoa : CK(243) : AC(32), DHA (Docosahexaenoic Acid) : CK(582) : AC(100), Fish Oil : CK(615) : AC(95), Folic Acid : CK(542) : AC(77), Genistein : CK(450) : AC(174), Hops : CK(51) : AC(20), Policosanol : CK(184) : AC(22), Sesame Seeds : CK(151) : AC(27), Vitamin D : CK(1682) : AC(238)

Diseases : Alzheimer's Disease : CK(826) : AC(160), Neurodegenerative Diseases : CK(1743) : AC(420)

Policosanol is at least as effective as various statin drugs in decreasing the progression and increasing regression of cardiovascular disease.

Click here to read the entire abstract

Pubmed Data : Altern Med Rev. 2002 Jun;7(3):203-17. PMID: 12126462

Article Published Date : Jun 01, 2002

Study Type : Review

Additional Links

Substances : Policosanol : CK(184) : AC(22)

Diseases : Cardiovascular Diseases : CK(5138) : AC(641)

Additional Keywords : Natural Substances Versus Drugs : CK(988) : AC(165), Policosanol Safety Tests : CK(1) : AC(1), Superiority of Natural Substances versus Drugs : CK(826) : AC(164)

Health Guide: Heart Health

Related Blogs

The Evidence Against Aspirin And For Natural Alternatives

Written by Sayer Ji, Founder

As far back as the 5th century BC the Greek physician Hippocrates wrote about the use of a bitter powder extracted from willow bark that reduced fevers and eased aches and pains. Native Americans also used an infusion of willow bark for similar purposes. What was this remarkable "healing" principle within the bark that relieved dis-ease?

Sugarcane Extract Superior To Cholesterol-Lowering Drugs?

Written by Sayer Ji, Founder

There is a little known natural extract of plant waxes known as policosanol, extractable from sugar cane, yams, and beeswax, which has been giving some of the more profitable drugs on the market a biomedical beating since it was first investigated in clinical trials by the Cubans in the 1990's.

FAIL: Merck's Statin Drug Found No Better Than Coconut Water

Written by Sayer Ji, Founder

In a 2008 study published in the journal Food Chemistry & Toxicology titled, "Comparative evaluation of the hypolipidemic effects of coconut water and lovastatin in rats fed fat-cholesterol enriched diet," the beverage coconut water was as effective as Merck's original cholesterol-lowering drug in positively modulating blood lipid levels in rats.

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version
Send to friend
PDF version